Clinical Trials on Transplant Sensitization in Ireland

Total 10 results

University Medical Center Groningen
Dutch Kidney Foundation; Innovation Fund of the Dutch Medical Insurance Companies

Completed

ACtive Care After Transplantation, the ACT Study (ACT)

Metabolic Syndrome | Kidney Transplant | Post-transplant Weight Gain

Netherlands
Astellas Pharma Europe Ltd.

Completed

A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant (ADDRESS)

Liver Transplant | Kidney Transplant

Italy, Spain, Belgium, Germany, Latvia, Canada, Korea, Republic of, Czechia, Austria, Finland, Belarus, Estonia, France, Hungary, Ireland, Netherlands, Poland, Portugal, Romania, Russian Federation, Slovakia, Sweden, Switzerland, United...
Pfizer

Completed

Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus

Kidney Transplant

United States, Brazil, Australia, South Africa, Germany, Hungary, Poland, Israel, Canada, Austria, Argentina, Mexico
Natera, Inc.
University of Maryland

Recruiting

The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) (ProActive)

Kidney Transplant Rejection

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Kidney Transplant

Spain, Italy, Argentina, Greece, Taiwan, Singapore, United States, Canada, United Kingdom, Chile, South Africa, Hungary, Turkey, Austria, Germany, France, Norway, Australia, Sweden, Portugal, Cyprus
CareDx

Active, not recruiting

Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry (KOAR)

Kidney Transplant Rejection

United States
Mallinckrodt

Terminated

Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide

Sickle Cell Disease | Pulmonary Hypertension | Lung Disease | Lung Transplant | Cardiac Transplant

United States
Novartis Pharmaceuticals

Completed

Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

Liver Transplant Recipient

Belgium, Spain, Germany, Italy, Australia, United States, Netherlands, Ireland, Sweden, Brazil, Colombia, France, Russian Federation, Argentina, Czechia, United Kingdom
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
Region Stockholm
Uppsala University

Recruiting

Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation (SACK)

Stroke | Chronic Kidney Diseases | Death | Atrial Fibrillation | Intracerebral Hemorrhage | Kidney Transplant; Complications | Thromboses, Venous | Cardiovascular Complication | Major Bleed

Sweden, Norway, Finland, Iceland

Clinical Trials on Transplant Sensitization in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations